BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT
BeOne Medicines Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -177.64M | -392.37M | -644.79M | -860.46M | -523.7M | -784.43M | -881.71M | -959.49M | -1.73B | -1.92B | -2B | -2.14B | -2.01B | -1.91B | -1.41B | -1.3B | -1.31B | -1.17B |
Depreciation & Amortization | 189.96M | 179.27M | 171.76M | 145.34M | 95.55M | 92.96M | 87.67M | 81.87M | 76.56M | 69.69M | 66.28M | 61.38M | 57.36M | 53.42M | 46.46M | 41.16M | 37.33M | 33.67M |
Stock-Based Compensation | 468.6M | 448.43M | 441.67M | 426.83M | 408.25M | 380.94M | 367.62M | 352.96M | 335.02M | 313M | 303.16M | 288.05M | 276.95M | 260.43M | 240.71M | 227.16M | 210.38M | 191.06M |
Other Working Capital | 184.81M | 208.06M | 142.28M | 224.29M | -12.69M | -25.18M | -62.77M | -253.02M | -194.87M | -100.25M | -110.68M | 321.08M | 344.44M | 199.87M | 438M | 121.55M | 180.45M | 225.29M |
Other Non-Cash Items | 56.72M | 56.52M | 47.9M | -27.94M | -374.87M | -360.6M | -361.19M | -343.87M | -724K | -12.05M | 3.31M | -10.53M | -45.65M | -4.57M | -13.11M | -33.84M | 26.43M | -42.72M |
Deferred Income Tax | n/a | n/a | n/a | -46K | 704K | 653K | 689K | 2.41M | -5.51M | 7.38M | 2.06M | -2.3M | -21.22M | -34.12M | -41.09M | -57.45M | -39.06M | -39.85M |
Change in Working Capital | 33.58M | -79.83M | -157.17M | -121.29M | -309.91M | -231.84M | -370.54M | -387.75M | -415.43M | -283.81M | 132.39M | 121.26M | 117.72M | -21.43M | -118.34M | 104K | 104.28M | 210.5M |
Operating Cash Flow | 571.21M | 212.02M | -140.63M | -437.43M | -703.95M | -902.25M | -1.16B | -1.25B | -1.74B | -1.82B | -1.5B | -1.69B | -1.62B | -1.66B | -1.3B | -1.12B | -973.75M | -816.42M |
Capital Expenditures | -386.37M | -452.49M | -529.14M | -603.57M | -652.21M | -663.73M | -596.26M | -599.37M | -545.73M | -474.55M | -469.1M | -457.46M | -395.85M | -384.09M | -314.85M | -213.18M | -221.31M | -215.39M |
Cash Acquisitions | n/a | n/a | n/a | 9.95M | 34.37M | 34.37M | 34.37M | -135.48M | -438.03M | -1.15B | -1.15B | -1.03B | -752.41M | -43.41M | -34.91M | 28.5M | 75M | 75M |
Purchase of Investments | n/a | n/a | n/a | -1.39M | -5.39M | -15.91M | -16.98M | -18.24M | -17.47M | -17.96M | -17.4M | -143.24M | -845.83M | -1.43B | -2.19B | -2.87B | -4.6B | -5.15B |
Sales Maturities Of Investments | 1.8M | 1.8M | 2.65M | 108.38M | 108.39M | 298.93M | 673.24M | 778.74M | 1.08B | 1.61B | 1.56B | 1.74B | 2.2B | 2.37B | 3.15B | 3.54B | 3.75B | 3.6B |
Other Investing Acitivies | -91.47M | -69.77M | -21.87M | -30.7M | -54.88M | -44.55M | -34.37M | 135.48M | 438.03M | 1.14B | 1.15B | 1.04B | 759.91M | 43.41M | 34.91M | -33.98M | -80.47M | -75M |
Investing Cash Flow | -416.03M | -460.46M | -548.35M | -517.33M | -569.72M | -390.89M | 60M | 161.12M | 516.88M | 1.11B | 1.08B | 1.15B | 966.22M | 559.1M | 640.66M | 444.62M | -1.08B | -1.76B |
Debt Repayment | -114.02M | -99.56M | 145.08M | 502.08M | 411.68M | 559.73M | 360.77M | -104.58M | 92.93M | -94.25M | -65.94M | 37.19M | -53.73M | -3.28M | 101.53M | 165.99M | 168.13M | 206.77M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 123.4M | 96.94M | 48.37M | 42.94M | 43.9M | 38.91M | 55.71M | 63.64M | 63.16M | 66.67M | 46.96M | 46.25M | 76.13M | 78.89M | 92.76M | 361.93M | 224.97M | 231.69M |
Financial Cash Flow | 9.39M | -2.62M | 193.45M | 545.02M | 455.58M | 598.64M | 416.48M | -40.94M | 156.09M | -27.57M | -18.97M | 3.48B | 3.47B | 3.52B | 3.64B | 577.91M | 2.46B | 2.51B |
Net Cash Flow | 168.16M | -276.85M | -547.24M | -367.46M | -803.64M | -736.33M | -689.05M | -1.12B | -1.11B | -810.68M | -507.85M | 2.81B | 2.75B | 2.44B | 2.99B | -80.02M | 436.79M | -49.41M |
Free Cash Flow | 184.84M | -240.47M | -669.77M | -1.04B | -1.36B | -1.57B | -1.75B | -1.85B | -2.28B | -2.3B | -1.97B | -2.14B | -2.02B | -2.04B | -1.61B | -1.34B | -1.2B | -1.03B |